REGISTER FOR THIS ACTIVITY THROUGH THE TCACC SITE HERE

DUE TO EXTENUATING CIRCUMSTANCES, THIS ACTIVITY HAS BEEN TENTATIVELY RESCHEDULED FOR SATURDAY, SEPTEMBER 12, 2020.

This course will present current concepts in cardio-oncology, a bridging discipline at the intersection of cardiovascular medicine, hematology and oncology. The course will describe strategies to recognize and manage cardiovascular risks and complications in patients with cancer and cancer survivors. The format will include interactive case-based discussions and didactic lectures presented by national and regional expert faculty. The material presented in this course will be applicable to all practitioners involved in the care of patients undergoing or with a prior treatment for cancer and at risk or with active cardiovascular conditions.

Target Audience

This course is designed for General Practitioners and specialists in Internal Medicine, Cardiology, Hematology-Oncology, Advanced Practice Providers, Nurses, Residents, and Fellows in training.

Learning Objectives

Identify and discuss cardiovascular risks in cancer patients before treatment with potentially cardiotoxic cancer therapy
Recognize the appropriate diagnostic and treatment methods for different cardiotoxic complications
Identify key components for maintaining cardiovascular health after cancer treatment

Course summary

Available credit:

7.00 AMA
7.00 Attendance

Course opens:

09/12/2020

Course expires:

09/11/2021

Event starts:

09/12/2020 - 7:00am CDT

Event ends:

09/12/2020 - 5:00pm CDT

Cost:

$0.00

Add to calendar:

Rating:

Committee member(s)

Carlos Arteaga, Professor & Director, Simmons Comprehensive Cancer Center, Internal Medicine, Office of the Dean - Southwestern Medical School

has a financial relationship (Professional Services) with Novartis;.

has a financial relationship (Professional Services) with Merck;.

has a financial relationship (Professional Services) with ARVINAS;.

has a financial relationship (Grant Or Contract) with Pfizer;.

has a financial relationship (Professional Services) with Daiichi Sankyo;.

has a financial relationship (Professional Services) with Immunomedics;.

has a financial relationship (Professional Services) with Susan G. Komen;.

has a financial relationship (Stock Options) with Provista;.

has a financial relationship (Professional Services) with TAIHO Oncology;.

has a financial relationship (Professional Services) with OrigiMed;.

has a financial relationship (Professional Services) with Athenex;.

has a financial relationship (Grant Or Contract) with Lilly;.

has a financial relationship (Professional Services) with Lilly;.

has a financial relationship (Professional Services) with AstraZeneca;.

has a financial relationship (Professional Services) with Sanofi;.

Available Credit

7.00 AMA
7.00 Attendance

Price